In charge of putting in place and maintaining main bioinformatics pipelines; expertise in differential expression & other RNA analysis. Working on QTLs in Parkinson's disease data.

marjorie.labrecque@umontreal.ca

Expert in molecular biology experimental techniques with a primary interest in the field of lipidomics in Parkinson's disease. 

Laura.Hamilton.chum@ssss.gouv.qc.ca

Focuses on genetic etiology of patients with Myopathies and Muscular Dystrophies by integrating omics data using a personalized bioinformatics pipeline.

valerie.triassi@umontreal.ca   or   valerie.triassi.chum@ssss.gouv.qc.ca

Transcriptomic and epigenetic etiology and signatures in Parkinson's Disease and other atypical parkinsonisms

lovatiana.andriamboavonjy@umontreal.ca

Genetic etiology of Episodic Ataxias through multiomics (WGS & RNA-seq) and transcriptomic analysis of candidate genes utilizing Long-Read Sequencing.

sebastien.audet.4@umontreal.ca

Functional assessment of the impact of IARS variants using myoblasts trans-differenciated from patient's fibroblasts, in parallel to a CRISPR-Cas9 gene edited culture of immortalized myoblasts. 

adrien.rihoux@umontreal.ca

Proteomic study aiming to define the immune profile of Parkinson Patients using the O-link technology as well as other approaches. 

saiyet.de.la.caridad.baez.llovio@umontreal.ca

Analysis of large sequencing cohorts to identify potentially pathogenic variant over-representation in Quebec populations.

annelie.de.mori@umontreal.ca

Working on the integration of tools to analyse repeat expansions and differential methylation in Long-Read Sequencing data in the context of neurodegenerative disorders. 

carolane.charest@umontreal.ca

Starting an internship that will focus on cellular disease modelling.

Evaluated the relevance of RYR1 and IARS genes in muscular disorders.

Now works at the Ottawa Hospital Research Institute. 

Studied the mitochondrial antigen presentation response in Parkinson.

Currently pursuing her PhD at the IRCM in Montreal.

Applying multimodal single cell RNAseq approaches for the identification of cellular and molecular biomarkers in Parkinson’s Disease patients.

gael.moquin-beaudry@umontreal.ca

Genetic etiology of Neuromuscular Diseases - Utilization of CRISPR technologies to design representative cellular models. 

jean.mezreani@umontreal.ca

Generation of MLIP knock-in and knock-out in immortalized human myoblasts for the functional assessment of its role in myopathies. 

alexie.gagne@umontreal.ca

Generation of cellular model carrying ITPR1 variants with CRISPR/Cas9 for the functional validation of its role in altered calcium release in ataxia patients.

Currently pursuing a MD at University of Montreal.